Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study

Bibliographic Details
Title: Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study
Authors: Katharina Kusejko, Roger D. Kouyos, Enos Bernasconi, Katia Boggian, Dominique L. Braun, Alexandra Calmy, Matthias Cavassini, Christian van Delden, Hansjakob Furrer, Christian Garzoni, Hans H. Hirsch, Cedric Hirzel, Oriol Manuel, Patrick Schmid, Nina Khanna, Fadi Haidar, Marco Bonani, Dela Golshayan, Michael Dickenmann, Daniel Sidler, Aurelia Schnyder, Nicolas J. Mueller, Huldrych F. Günthard, Peter W. Schreiber, the Swiss HIV Cohorts Study and the Swiss Transplant Cohort Study
Source: BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Publisher Information: BMC, 2024.
Publication Year: 2024
Collection: LCC:Infectious and parasitic diseases
Subject Terms: Kidney transplantation, HIV, Infectious disease events, Infectious and parasitic diseases, RC109-216
More Details: Abstract Background Since the implementation of universal antiretroviral therapy, kidney transplantation (K-Tx) has become a valuable option for treatment of end-stage kidney disease for people with HIV (PWH) with similar patient and graft survival as compared to HIV-uninfected patients. Little is known about the hazards and manifestations of infectious disease (ID) events occurring in kidney transplant recipients with HIV. Methods Using linked information collected in the Swiss HIV Cohort Study (SHCS) and the Swiss Transplant Cohort Study (STCS), we described in-depth demographical and clinical characteristics of PWH who received a K-Tx since 2008. Further, we performed recurrent time to event analyses to understand whether HIV was an independent risk factor for ID events. Results Overall, 24 PWH with 57 ID events were included in this study (100% match of SHCS to STCS). Of these, 17 (70.8%) patients had at least one ID event: 22 (38.6%) viral (HIV not counted), 18 (31.6%) bacterial, one (1.8%) fungal and 16 (28.1%) probable infections. Most ID events affected the respiratory tract (25, 37.3%) or the urinary tract (13, 19.4%). Pathogen types and infection sites were similar in PWH and a matched control group of HIV-uninfected patients. HIV was not an independent risk factor for ID events (adjusted hazard ratio 0.94, p = 0.9). Conclusion By linking data from two large national Swiss cohorts, we provided in-depth information on ID events in PWH receiving a K-Tx in Switzerland. HIV infection was not associated with an increased hazard for ID events after K-Tx.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1471-2334
Relation: https://doaj.org/toc/1471-2334
DOI: 10.1186/s12879-024-10026-7
Access URL: https://doaj.org/article/767aac18d19743259b911d3faa36bd3c
Accession Number: edsdoj.767aac18d19743259b911d3faa36bd3c
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:14712334
DOI:10.1186/s12879-024-10026-7
Published in:BMC Infectious Diseases
Language:English